Remote Senior Director, Cardiometabolic Drug Development

KCR Placement; Cambridge (MA); Remote; USD 210,000 - 320,000; Full time

Benefits offered by this job

Health insurance

Retirement plan

Global mobility

Job summary

ICON plc is seeking a Senior Director for Drug Development & Consulting with cardiometabolic expertise. You will advise senior stakeholders, design asset-focused strategies, and lead complex Cardiometabolic programs across the full lifecycle. This is a highly visible, client-facing role with global collaboration.

You will engage with CMO and TA heads, guide study strategy, and drive pre-sales efforts while mentoring teams and advancing liver disease drug development capabilities.

Qualifications

• Deep, recognized expertise in Cardiometabolic and liver disease drug development.
• Proven ability to operate in a strategic, client-facing, consultative environment.
• Experience engaging senior scientific and clinical stakeholders across industry and academia.

Responsibilities

• Lead strategic Cardiometabolic drug development design across liver diseases (MASLD/MASH, ALD, cirrhosis, hepatitis).
• Own end-to-end protocol development for Cardiometabolic trials (Phases I–IV).
• Provide expert guidance on development strategy and data interpretation to senior client stakeholders.
• Lead proposal development, study strategy, and bid defense within Cardiometabolic.
• Build relationships with KOLs and regulatory authorities; contribute to service offerings.

Skills

Cardiometabolic expertise

Strategic leadership

Client-facing

Communication skills

Education

MD (Cardiometabolic focus)

Job description

ICON plc is seeking a Senior Director for Drug Development & Consulting with cardiometabolic expertise. You will advise senior stakeholders, design asset-focused strategies, and lead complex Cardiometabolic programs across the full lifecycle. This is a highly visible, client-facing role with global collaboration.

You will engage with CMO and TA heads, guide study strategy, and drive pre-sales efforts while mentoring teams and advancing liver disease drug development capabilities.